| Name | Title | Contact Details |
|---|
At Seabrook, we are dedicated to doing everything we can to make our customers successful. We are a contract manufacturer of medical devices specializing in surgical instruments, implants and devices for the orthopaedic market. In addition to the high
Áegis Living is a national leader in assisted living and memory care. Providing the finest in senior lifestyle and living options, “We`re the people who make life better” emphasizes health, quality of life, well-being and community. Founded in 1997 and headquartered in Redmond, WA, privately-held Áegis Living operates 30 communities in Washington, California and Nevada, with five currently in development.
Cedarhurst Senior Living is a company that operates Independent Living, Assisted Living, Personal Care, and Memory Care communities under the Cedarhurst Senior Living, Cedar Ridge and Cedar Creek brands.
ERBA Diagnostics Inc., is a part of the global ERBA Mannheim Group. Earlier known by the name of IVAX Diagnostics, the company specializes in manufacture and marketing of proprietary diagnostic reagents, test kits and instrumentation in the areas of autoimmune, chemistry, hematology, diabetes and infectious diseases. ERBA Diagnostics has further strengthened ERBA Group`s comprehensive portfolio of instrument and reagent solutions, covering all levels of automation and throughput needs of laboratories across the world. With its team of experienced marketing, technical and service professionals and a strong and extensive distribution network the company lives up to the ERBA Group`s philosophy of consistently delivering excellence through innovation, technology and customer service.
Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD). We use advanced machine learning and computer vision to interpret endoscopic images along with other types of data, helping clinicians to better assess patients with potential GI problems. This gives practitioners enhanced capabilities in the detection, annotation, disease scoring and treatment of GI related diseases. Iterative Health is initially applying these advances towards standardizing disease severity characterization for inflammatory bowel disease. Ultimately, the company aims to establish more meaningful endpoints to serve as better predictors of both therapeutic response and disease outcomes. The company is headquartered in Cambridge, Massachusetts.